FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/10/2026
Back to search
Official data from USPTO
KADMOS BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KADMOS BIOTECH
ST13
US500000079410821Class
1, 5, 10, 42, 44
Filing
79410821
Registration
8122471
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
08/10/2026
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
05/27/2024
Registration date
02/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
08/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Kadmos Biotech GmbH
Representatives
Mark P. Stone Law Office of Mark P. Stone
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical substanceschemical materials and chemical preparations and biological materialshuman stem cells and iPSC-derived cells and extracellular matrix which can be comprised of proteinspeptidespolysaccharidesamino acidslipidsenzymesgrowth factors and biopolymersfor use in the field of oral medical therapy or for research purposesin particularfor dental and jaw restoration purposes; stem cells for research purposes; stem cells for scientific purposes.
Class 5
Medical and veterinary preparations for use in the field of oral medical therapy for dental and jaw restoration purposes; stem cells for medical purposes; medicated dental care preparations for the treatment of periodontal diseases and for promoting oral tissue regeneration; dental filling materialsdental cements.
Class 10
Medical and veterinary apparatus and instruments for use in the field of oral medical therapy for dental and jaw restoration purposes; apparatus for the regeneration of stem cells for medical purposes; dental prostheses; artificial jaws; dental implants being prosthesis made of artificial materials for use in dentistry; dental implants being prosthesis made of artificial materials for use in jawbone surgery; dental implants and prostheticscell-based and tissue-engineeerd implants composed of biologicalbiocompatible or composite materials for use in dental and jawbone regeneration.
Class 42
Science and technology servicesscientific research in the fields of oral medical therapydental and jaw restorationregenerative medicine; medical and pharmacological research services; research in the field of dental biomechanics; stem cell research services; product research and development in the field of oral medical therapy for dental and jaw restoration purposes.
Class 44
Medical services relating to the removaltreatment and processing of stem cells; stem cell storagestem cell bank services; regenerative dentistry services; advice relating to dentistry; oral surgery services; orthodontic services.
Publications
History of USPTO decisions and trademark events.
27 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/10/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/14/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/03/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/27/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/27/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/16/2025
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2025
RFNT
REFUSAL PROCESSED BY IB
09/27/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/06/2025
RFRR
REFUSAL PROCESSED BY MPU
09/06/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/31/2025
CNRT
NON-FINAL ACTION WRITTEN
07/30/2025
DOCK
ASSIGNED TO EXAMINER
07/30/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/29/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/28/2024
Continuous trademark protection
Get notified about every new filing that threatens KADMOS BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.